Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Health Industry Groups Press For Diagnostics Reform Bill

Executive Summary

Almost 50 stakeholder groups have signed onto a letter to US Congressional leadership that asks lawmakers to pass the VALID Act, which would update the country’s approach to diagnostic test regulation. Congress needs to pass a user fee package this month to ensure full FDA funding.

You may also be interested in...



‘Skinny’ User-Fee Reauthorization Would Leave Out Diagnostics Reform

A stripped-down version of the US FDA user-fee reauthorization package may be the best Congress can do before the August recess, but some say it won’t be enough. 

OIG: FDA’s EUA Approach Allowed Bad Tests To Reach Market

A review by a government watchdog found the FDA’s review process for COVID-19 diagnostics was plagued by issues including allowing low-quality tests to slip through, high reviewer workloads, and manufacturer frustration.

US FDA Finalizes Medical Device Electronic Submissions Guidance

The guidance document explains the history of and requirements for electronic submissions of 510(k)s. 

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT145644

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel